TWST
Twist Bioscience Corporation
102.25
2 x 75.13
2 x 129.61
bid
ask
-
0.63
0.61%
2 @ 04:00 PM
105.00 +2.75 (2.69%)
| Ytd | 222.35% | |
| 1y | 171.36% |
99.91
day range
104.38
23.30
52 week range
104.65
| Open | 101.16 | Prev Close | 102.88 | Low | 99.91 | High | 104.38 | Mkt Cap | 6.37B |
| Vol | 1.50M | Avg Vol | 1.72M | EPS | -1.32 | P/E | N/A | Forward P/E | -134.78 |
| Beta | 2.21 | Short Ratio | 9.72 | Inst. Own | 123.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 68.89 | 200-d Avg | 45.98 | 1yr Est | 74.10 |
| Income Statement | |||
| Total Revenue | 110.72M | ||
| Revenues (USD) | 110.72M | ||
| Cost of Revenue | 53.59M | ||
| Gross Profit | 57.12M | ||
| Operating Expenses | 102.99M | ||
| Research and Development Expense | 19.70M | ||
| Selling, General and Administrative Expense | 76.08M | ||
| Operating Income | -45.86M | ||
| Income Tax Expense | 43.00K | ||
| Net Income | -44.02M | ||
| Net Income Common Stock | -44.02M | ||
| Net Income Common Stock (USD) | -44.02M | ||
| Consolidated Income | -44.02M | ||
| Earnings per Basic Share | -0.71 | ||
| Earnings per Basic Share (USD) | -0.71 | ||
| Earnings per Diluted Share | -0.71 | ||
| Earning Before Interest & Taxes (EBIT) | -43.98M | ||
| Earning Before Interest & Taxes (USD) | -43.98M | ||
| Weighted Average Shares | 61.70M | ||
| Weighted Average Shares Diluted | 61.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 122.67M | ||
| Cash and Equivalents (USD) | 122.67M | ||
| Investments | 119.27M | ||
| Investments Current | 49.00M | ||
| Investments Non-Current | 70.27M | ||
| Trade and Non-Trade Receivables | 64.15M | ||
| Current Assets | 323.44M | ||
| Property, Plant & Equipment Net | 181.88M | ||
| Total Assets | 676.21M | ||
| Debt Current | 10.44M | ||
| Total Debt | 110.84M | ||
| Current Liabilities | 119.98M | ||
| Debt Non-Current | 100.40M | ||
| Total Liabilities | 221.12M | ||
| Accumulated Retained Earnings (Deficit) | -1.39B | ||
| Accumulated Other Comprehensive Income | -639.00K | ||
| Shareholders Equity | 455.09M | ||
| Shareholders Equity (USD) | 455.09M | ||
| Assets Non-Current | 352.78M | ||
| Total Debt (USD) | 110.84M | ||
| Goodwill and Intangible Assets | 95.19M | ||
| Inventory | 33.52M | ||
| Liabilities Non-Current | 101.14M | ||
| Trade and Non-Trade Payables | 14.68M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.41M | ||
| Net Cash Flow from Financing | 4.14M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -26.13M | ||
| Capital Expenditure | -7.99M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -5.00M | ||
| Issuance (Purchase) of Equity Shares | 4.15M | ||
| Net Cash Flow from Investing | -12.71M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 281.00K | ||
| Net Cash Flow from Operations | -17.56M | ||
| Effect of Exchange Rate Changes on Cash | -6.00K | ||
| Share Based Compensation | 18.94M | ||